Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laxminarayan Rawat, Ph.D.

Concepts (31)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Laxminarayan Rawat's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Laxminarayan Rawat has written about over time.
Antineoplastic Agents, Phytogenic, 1 publications between 2020 and 2020, average publication date May 2020. Antineoplastic Combined Chemotherapy Protocols, 1 publications between 2020 and 2020, average publication date May 2020. Cell Death, 1 publications between 2020 and 2020, average publication date May 2020. Colorectal Neoplasms, 1 publications between 2020 and 2020, average publication date May 2020. HCT116 Cells, 1 publications between 2020 and 2020, average publication date May 2020. Dioxolanes, 2 publications between 2020 and 2022, average publication date March 2021. Doxorubicin, 2 publications between 2020 and 2022, average publication date March 2021. Apoptosis, 1 publications between 2022 and 2022, average publication date January 2022. Cyclin-Dependent Kinase Inhibitor p21, 1 publications between 2022 and 2022, average publication date January 2022. Drug Synergism, 1 publications between 2022 and 2022, average publication date January 2022. Osteosarcoma, 1 publications between 2022 and 2022, average publication date January 2022. Piperidones, 1 publications between 2022 and 2022, average publication date January 2022. Smad4 Protein, 1 publications between 2022 and 2022, average publication date January 2022. Tumor Suppressor Protein p53, 1 publications between 2022 and 2022, average publication date January 2022. Reactive Oxygen Species, 3 publications between 2020 and 2023, average publication date February 2022. Oxidative Stress, 2 publications between 2020 and 2023, average publication date February 2022. Carcinoma, Renal Cell, 1 publications between 2023 and 2023, average publication date October 2023. Heme Oxygenase-1, 1 publications between 2023 and 2023, average publication date October 2023. Kidney Neoplasms, 1 publications between 2023 and 2023, average publication date October 2023. NF-E2-Related Factor 2, 1 publications between 2023 and 2023, average publication date October 2023.

To see the data from this visualization as text, click here.
Rawat's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (31)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.